It was demonstrated that DSG2 expression was increased in non-small cell lung cancer, skin carcinomas and human colon adenocarcinomas, implying a possible oncogenic function of DSG2 protein [10,11,12]. This evidence concerns the gene DSG2 and colon adenocarcinoma.